Clinical trial
A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults
NCT00113880 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00113880 |
|---|---|
| Title | A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults |
| Official title | Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy |
| Intervention type | Biological |
| Interventions | FluMist |
| Enrollment | 63,061 |
| Start date | Oct 1, 2003 |
| Primary completion | Sep 1, 2008 |
| Completion | Jun 1, 2010 |
| First posted | Jun 13, 2005 |
| Last update posted | Jan 8, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: